When erections become less reliable, it is natural to look for an approach that addresses more than one possible cause. Shockwave Clinic may discuss low-intensity extracorporeal shockwave therapy (ESWT) alongside platelet-rich plasma (PRP) and other options. There is reason to study combinations—but men deserve a clear distinction between promising results and what has actually been proven.
What is known about ESWT for erectile dysfunction?
Low-intensity ESWT has been tested in randomised clinical trials. The European Association of Urology (EAU) guideline concludes that it may produce a mild improvement in erectile function for selected men with vasculogenic ED and gives it a weak recommendation. Some men improve; others do not. Treatment does not replace an assessment of cardiovascular, metabolic, hormonal, medication-related or psychological factors.
What is known about PRP?
PRP is prepared from a patient’s own blood. Early ED trials have reported encouraging changes in erectile-function scores, but preparation methods and treatment schedules vary. The EAU guideline says evidence is still insufficient to recommend intracavernous PRP in routine practice and advises its use only in a clinical-trial setting. We discuss that status, injection risks, costs and established alternatives before any decision.
Does adding PRP to ESWT work better?
The combination has been studied, but findings are not uniform. A 2021 retrospective comparison found improvement in both ESWT-only and ESWT-plus-PRP groups, without a statistically significant difference in erectile-function improvement between them when compared by ED grade. A 2025 review of seven randomised trials reported a favourable subgroup signal for adding PRP to shockwave therapy. Differences in study design, protocols and patient groups mean this should be presented as emerging evidence, not proof that every combined programme is superior or that results last longer.
It is therefore inaccurate to promise faster recovery, permanent vascular regeneration, less medication, increased penile length or curvature correction from ESWT plus PRP. Those are separate outcomes needing their own evidence. If a man also has Peyronie’s disease, shockwave may be considered for pain in the active phase, but current urology guidance does not recommend it to correct curvature.
Where does EMTT fit in our clinic programme?
For selected patients, our clinic may offer electromagnetic transduction therapy (EMTT) alongside focused ESWT and, where appropriate, other support. This is an emerging, personalised approach. We have not identified a published ED trial establishing that adding EMTT improves results beyond ESWT alone. Research on combinations may give clearer answers in future. We will explain the purpose, uncertainty and cost of each component rather than present the full protocol as a proven cure.
What might a sensible treatment plan look like?
The first step is to understand the cause and severity of ED and what you want to change. Some men benefit from lifestyle or cardiovascular risk treatment, medication, counselling or a vacuum device; others may wish to discuss ESWT. A combination should be considered only after reviewing its potential benefits, risks, alternatives and evidence gaps. Progress can be followed through your experience and a recognised erectile-function measure, rather than a promised timetable.
If length loss or a Peyronie’s bend is also worrying you, ask about a separate assessment. A randomised traction trial gives encouraging length data for a specific device and schedule, but that cannot be attributed to ESWT, PRP or EMTT.
A hopeful, honest conversation
Better erectile function is possible for some men, and the science is moving forward. Our role is to help you choose a plan that fits your health and priorities without claiming that every technology has the same level of proof. Explore our ED programme or request a confidential assessment.
This article is general information, not a diagnosis or guarantee of treatment results. Suitability and outcomes vary.
